April 20, 2021
Tryp Therapeutics Reports on Key Milestones for 2021
April 20, 2021
Tryp Therapeutics Reports on Key Milestones for 2021
San Diego, California--(Newsfile Corp. - April 20, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, reported today on the Company's significant progress…
April 20, 2021
Mindset Pharma Announces Strong Confirmation of In Vivo Proof-of-Concept Across Its Entire New Drug Program Portfolio
Toronto, Ontario--(Newsfile Corp. - April 20, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") is pleased to announce, that based on data derived from Mindset's in vivo testing program (i.e. testing in animal subjects) carried out by InterVivo Solutions…
April 19, 2021
Mindset Pharma Announces Exercise of Over-Allotment Option for Additional Gross Proceeds of $1.052 Million
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") is pleased to announce that in connection with its previously announced "bought deal" public offering (the "Offering") underwritten by Canaccord Genuity Corp.…
April 15, 2021
Mindset Pharma Announces Closing of $7.5 Million Bought Deal Public Offering
Toronto, Ontario--(Newsfile Corp. - April 15, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") is pleased to announce that it has completed the previously announced "bought deal" public offering through the issuance of an aggregate of 10,000,000 units…
April 15, 2021
Tryp Therapeutics to Host Investor Day on April 22
San Diego, California--(Newsfile Corp. - April 15, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, is pleased to announce that it will be hosting…
April 14, 2021
Psyched Wellness Receives DTC Eligibility
Toronto, Ontario--(Newsfile Corp. - April 14, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE:5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce…
April 7, 2021
New Wave Subsidiary, Way of Will Inc., Confirms Plans to Expand Brand Presence on Walmart.com
TORONTO, April 7, 2021 /CNW/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital and support services, announced that it will set forth its plans to aggressively increase its brand presence on Walmart.com.…
Track the Horizons Psychedelic Stock Index ETF
April 15, 2021
Mindset Pharma Announces Closing of $7.5 Million Bought Deal Public Offering
Toronto, Ontario--(Newsfile Corp. - April 15, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") is pleased to announce that it has completed the previously announced "bought deal" public offering through the issuance of an aggregate of 10,000,000 units…
April 15, 2021
Tryp Therapeutics to Host Investor Day on April 22
San Diego, California--(Newsfile Corp. - April 15, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, is pleased to announce that it will be hosting…
April 14, 2021
Psyched Wellness Receives DTC Eligibility
Toronto, Ontario--(Newsfile Corp. - April 14, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE:5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce…
April 7, 2021
New Wave Subsidiary, Way of Will Inc., Confirms Plans to Expand Brand Presence on Walmart.com
TORONTO, April 7, 2021 /CNW/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital and support services, announced that it will set forth its plans to aggressively increase its brand presence on Walmart.com.…
April 6, 2021
Lobe Sciences Appoints Ilan Hayman to Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - April 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Mr. Ilan Hayman, B.IS, ITIL Cert, M. ProjMngt to its Advisory Board. Philip Young, CEO and Director of Lobe states,…
April 6, 2021
NeonMind Developing Music Playlist for Psychedelic Therapy Sessions
Vancouver, British Columbia--(Newsfile Corp. - April 6, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (FSE: 6UF) (OTC PINK: NMDBF) ("NeonMind"), is pleased to announce the commencement of a three phase university study dedicated to creating an ideal music playlist to accompany therapeutic…
April 5, 2021
Tryp Therapeutics Announces Listing on OTCQB and DTC Eligibility
San Diego, California--(Newsfile Corp. - April 5, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company") a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced today it has initiated quoting activity on the…
April 1, 2021
Mindset Pharma Announces Filing of Amended and Restated FS and MD&A for the Three and Six Month Period Ended December 31, 2020
Toronto, Ontario--(Newsfile Corp. - April 1, 2021) - Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) (FSE: 9DF) ("Mindset" or the "Company") - Mindset announces that it has refiled its interim financial statements for the three and six month period ended December 31, 2020 (the "Financial…
April 1, 2021
Tryp Therapeutics Announces Amendment to Option Plan and Option Grant
San Diego, California--(Newsfile Corp. - April 1, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) ("Tryp" or the "Company"), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, is pleased to announce that it has amended the terms of its stock…
April 1, 2021
New Wave Subsidiary, Way of Will Inc., Announces Plans to Expand Brand Presence on Amazon US and Canada
TORONTO, April 1, 2021 /CNW/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital and support services, today announced its plans to expand Way of Will's brand presence on the e-commerce giant, Amazon.…
April 1, 2021
Tryp Therapeutics Appoints Greg McKee as Chief Executive Officer
San Diego, California--(Newsfile Corp. - April 1, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) ("Tryp" or the "Company"), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, is pleased to announce that it has appointed Greg McKee as its…
March 31, 2021
Lobe Sciences Becomes Enterprise Member of NFL Alumni Association
Vancouver, British Columbia--(Newsfile Corp. - March 31, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce it has become an official Enterprise Member of the NFL Alumni Association. As an Enterprise Member of The NFL Alumni Association…
March 30, 2021
New Wave subsidiary, Way of Will Inc., announces completion of production staff training as part of goal to becoming GMP certified
TORONTO, March 30, 2021 /CNW/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital and support services, is pleased to announce the successful completion of their production staff training last week as part of the…
March 30, 2021
Mindset Pharma Expands Scientific Team: Dr. Malik Slassi Appointed Senior VP Innovation and Ian Dean Appointed Director Preclinical Development
Toronto, Ontario--(Newsfile Corp. - March 30, 2021) - Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) (FSE: 9DF) ("Mindset" or the "Company"), a drug discovery and development company focused on developing next generation psilocybin and N,N-Dimethyltryptamine (DMT) inspired medicines and related…
March 30, 2021
Psyched Wellness Initiates Study on AME-1 Extract for Gut Health
Toronto, Ontario--(Newsfile Corp. - March 30, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company has…
March 30, 2021
NeonMind CEO Robert Tessarolo to Speak at the Psychedelic, Therapeutics, & Drug Development Conference
Vancouver, British Columbia--(Newsfile Corp. - March 30, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (FSE: 6UF) ("NeonMind"), a psychedelic drug development company, is pleased to announce that Robert Tessarolo, President & Chief Executive Officer, will be speaking at the Psychedelic,…
March 30, 2021
NeonMind CEO Robert Tessarolo to Speak at the Psychedelic, Therapeutics, & Drug Development Conference
Vancouver, British Columbia--(Newsfile Corp. - March 30, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (FSE: 6UF) ("NeonMind"), a psychedelic drug development company, is pleased to announce that Robert Tessarolo, President & Chief Executive Officer, will be speaking at the Psychedelic,…
March 29, 2021
Algernon Pharmaceuticals Announces its Addition to the Market’s First Psychedelic Stock Index ETF
VANCOUVER, British Columbia., March 29, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has been added to the Horizons Psychedelic Stock…
March 29, 2021
Lobe Sciences Added to Horizons Psychedelic Stock Index ETF
Vancouver, British Columbia--(Newsfile Corp. - March 29, 2021) - Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE: LOBE) (OTC Pink: GTSIF) is pleased to announce the Company has been added to the Horizons Psychedelic Stock Index ETF ("PSYK" or the "ETF") and its underlying index, the Horizons…
March 25, 2021
New Wave Subsidiary, Way of Will Inc., Announces Launch of Functional Mushroom Capsules and Functional Mushroom Powder as Part of New Emerging…
TORONTO, March 25, 2021 /CNW/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital and support services, is pleased to announce the launch of its first mushroom products in a new functional mushroom…
March 24, 2021
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, March 24, 2021 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food &…
March 23, 2021
New Wave Subsidiary, N2 Logics, Commences Phase Two of Way of Will’s E-commerce Optimization
TORONTO, March 23, 2021 /CNW/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital and support services, announced that N2 Logics has begun Phase Two of the e-commerce optimization strategy for Way of Will.…
March 23, 2021
Mindset Pharma and InterVivo Solutions to Jointly Develop Advanced Cooperative Psychedelics Evaluation Platform (“Cope”); Cope Expected to Be World’s First in Vivo Psychedelic Benchmark Data Set
Toronto, Ontario--(Newsfile Corp. - March 23, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a biotechnology company focused on developing next generation psychedelic medicines and related technologies, is pleased to announce that it has entered a…
March 23, 2021
NeonMind CEO Provides Update on the Progress of its Psilocybin Drug Development Research Plan and Team
Vancouver, British Columbia--(Newsfile Corp. - March 23, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTC: NMDBF) (FSE: 6UF) ("NeonMind"), provides an update from CEO Rob Tessarolo on its research and development activities, as well as its plan to further develop two of its synthetic…
March 22, 2021
MindMed Announces Inclusion in FTSE Russell Indexes
NEW YORK, March 22, 2021 /PRNewswire/ — MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company announced that effective as of Friday March 19th, 2021, MindMed has been added to the FTSE Global Micro-Cap Index (which represents $1.3 trillion in global market…
March 19, 2021
Numinus Announces Closing of $40-Million Bought Deal Financing
/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./ VANCOUVER, BC, March 19, 2021 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating……
March 19, 2021
Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of International Patent Application
TORONTO, March 19, 2021 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce positive results of a pre-clinical study…
March 19, 2021
Havn Life CEO to Present at Zooming With LD, a Leading Platform for Microcap Companies
CEO Tim Moore will appear on Tuesday, March 24th at 8:00 AM PT/ 11:00 AM ET Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural…
March 18, 2021
Pure Extracts Orders Cutting Edge Vitalis Cosolvent Injection System
VANCOUVER, British Columbia, March 18, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic…
March 18, 2021
New Wave Subsidiary, Way of Will Inc., Receives Purchase Order for Foot & Shoe Deodorant from Fitness Subscription Service Gainz Box
TORONTO, March 18, 2021 /CNW/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital and support services, announced the receipt of a 6,300-unit purchase order for Way of Will's 42 Foot & Shoe Deodorant from the…
March 18, 2021
Tryp Therapeutics Announces Provisional Patent Filing For Improved Administration of Psychedelics
La Jolla, California--(Newsfile Corp. - March 18, 2021) - Tryp Therapeutics (CSE: TRYP), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced today that it has submitted a provisional patent (US 63/161,070) to improve how…
March 17, 2021
Field Trip Health Ltd. Announces Closing of $95 Million Bought Deal Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, March 17, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is…
March 17, 2021
PSYC Expands Digital Media Presence with the Launch of the Industry’s First Video News Segment
Psychedelic Spotlight Debuts the Spotlight Roundup LAS VEGAS, NV, March 17, 2021 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) the first publicly traded digital media company within the emerging sector of medicinal psychedelics, is pleased to…
March 17, 2021
Mindset Pharma Announces DTC Eligibility for OTCQB(R) Venture Listing
Toronto, Ontario--(Newsfile Corp. - March 17, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on developing next generation psilocybin-inspired medicines and related technologies, is pleased to announce…
March 17, 2021
Psyched Wellness Submits a Provisional Patent Application For AME-1
Toronto, Ontario--(Newsfile Corp. - March 17, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company has…
March 16, 2021
Pure Extracts Orders First Shipment of Functional Mushrooms for e-Commerce Store
VANCOUVER, British Columbia, March 16, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic…
March 16, 2021
Mydecine Innovations Group Provides Update on European Operations
DENVER, March 16, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for…
March 16, 2021
New Wave Subsidiary, Way of Will Inc., Announces Receipt of Purchase Order for Nail & Cuticle Serum from Popular Self-Care Subscription Service…
TORONTO, ON, March 16, 2021 /CNW/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital and support services, is pleased to announce its receipt of a purchase order for 20,000 units of Way of Will's…
March 16, 2021
Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer
Pozar will lead sales, marketing, e-commerce and logistics for Havn Retail Vancouver, BC – Havn Life Sciences Inc. (CSE : HAVN) (FRA: 5NP) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural…
March 15, 2021
Psyched Wellness Announces Changes to the Board of Directors
Toronto, Ontario--(Newsfile Corp. - March 15, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to…
March 15, 2021
Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its Psychedelic Drug Candidates Pipeline With Novel DMT & 5-MeO-DMT Analogs
Toronto, Ontario--(Newsfile Corp. - March 15, 2021) - Mindset Pharma Inc. (CSE:MSET) (FSE: 9DF) ("Mindset" or the "Company") is pleased to announce that it has filed a sixth provisional patent application with the United States Patent and Trademark Office. This most recent patent application…
March 12, 2021
Ehave CEO Benjamin Kaplan to be Featured on Psychedelic Spotlight Segment of New to the Street Airing on NewsMax on Sunday March 14th at 10:00 AM EST and Fox Business March 15th at 7:30 PM EST
MIAMI, March 12, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today CEO and psychedelic thought leader, Benjamin Kaplan, will be featured on the Psychedelic Spotlight segment of…
March 11, 2021
Pure Extracts Sells First Shipment of Cannabis Oil Extracts to German Pharma Company
VANCOUVER, British Columbia, March 11, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic…
March 11, 2021
New Wave Subsidiary, N2 Logics Enters Partnership Agreement with Toronto-Based Naturopathic Doctor, Dr. Elizabeth Goldspink, to Collaborate on…
TORONTO, March 11, 2021 /CNW/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital and support services, announces that N2 Logics Inc. ("N2"), an entity in which New Wave owns a significant interest, has signed an…
March 11, 2021
New Wave Subsidiary, N2 Logics Enters Partnership Agreement with Toronto-Based Naturopathic Doctor, Dr. Elizabeth Goldspink
TORONTO, March 11, 2021 /CNW/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital and support services, announces that N2 Logics Inc. ("N2"), an entity in which New Wave owns a significant interest, has signed an…
March 11, 2021
NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity
Vancouver, British Columbia--(Newsfile Corp. - March 11, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTC: NMDBF) (FSE: 6UF) ("NeonMind") is pleased to announce that on March 10, 2021 NeonMind engaged Certara®, the global leader in model-informed drug development to provide strategic…
March 10, 2021
Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets
*NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES DENVER, March 10, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), is pleased to announce that it has entered into an…
March 10, 2021
Mindset Pharma to Present at the Stifel GMP Conference – Psychedelics: Addressing the Global Mental Health Crisis
Toronto, Ontario--(Newsfile Corp. - March 10, 2021) - Mindset Pharma Inc. (CSE:MSET) (FSE: 9DF) ("Mindset" or the "Company"), a biotechnology company focused on developing next generation psychedelic medicines and related technologies, is pleased to announce that James Lanthier, CEO, and Joseph…
March 10, 2021
Microdose Announces the Launch of Accredited Course Series “The Science of Psychedelics: Training for Medical Professionals”
TORONTO, March 10, 2021 /PRNewswire/ -- Microdose is pleased to announce The Science of Psychedelics: Training for Medical Professionals, an online, accredited course series for physicians, psychologists, social workers, mental health counsellors, pharmacists, and other medical professionals. The…
March 10, 2021
Pure Extracts Technologies Corp. Announces Listing of Warrants on the Canadian Securities Exchange Under the Symbol PULL.WT Commencing March 10, 2021
Not for distribution to United States newswire services or for release, publication, distribution ordissemination, directly or indirectly, in whole or in part, in or into the United States. VANCOUVER, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp.…
March 9, 2021
Tryp Therapeutics Appoints Luke Hayes as Chief Financial Officer
La Jolla, California--(Newsfile Corp. - March 9, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) ("Tryp" or the "Company"), a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, is pleased to announce that it has appointed…
March 9, 2021
Pure Extracts and ShroomBloom Sign Psychedelic Mushroom Supply Letter of Intent
VANCOUVER, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic…
March 9, 2021
Microdose Launches Special Report Spotlighting Intellectual Property & Patents in Psychedelic Drug Development
Microdose, the global leader in B2B psychedelic intelligence, is pleased to be releasing the IP & Patents Report, a special communique spotlighting vital information regarding intellectual property and patentability of novel psychedelic drugs, delivery mechanisms, and more, compiled by leading…
March 9, 2021
New Wave Subsidiary, Way of Will Inc., to Roll Out All-Natural SPF Lotion in 2022
TORONTO, March 9, 2021 /CNW/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital and support services, announces the development of an all-natural SPF lotion to be launched in 2022 that will become a part of Way…
Get Bi-Weekly Updates
Subscribe to the Market Insights Report
Each Wednesday and Saturday, we will send you a review of the latest price movements, financial analysis, and original insights on the emerging financial landscape of the psychedelic industry.
Get Bi-Weekly Updates
Subscribe to the Market Insights Report
Each Wednesday and Saturday, we will send you a review of the latest price movements, financial analysis, and original insights on the emerging financial landscape of the psychedelic industry.